Insignia Capital buys Metanexgen

Insignia Capital Group has acquired Bensalem, Pennsylvania-based Metanexgen, a provider of multi-channel marketing solutions for the pharmaceutical, biotech and medical device sectors. The sellers included DFW Capital Partners. No financial terms were disclosed.

PRESS RELEASE

WALNUT CREEK, Calif., April 15, 2015 /PRNewswire/ — Insignia Capital Group today announced the acquisition of metanexgen from DFW Capital Partners and the original Company founders. Terms of the transaction were not disclosed.

Based in Bensalem, PA, metanexgen is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners. The Company was created through the 2013 merger of MetaPharm, a provider of data-driven email and direct mail marketing services, and NexGen, a provider of online video and virtual meeting marketing services.

“We are thrilled about our new partnership with Insignia. We expect their strategic and operational expertise to be immensely valuable as we seek to accelerate our growth,” said Chris Wiltshire, President and CEO of metanexgen. “We have built a diverse multi-channel marketing solution set to serve our clients’ growing needs. With Insignia’s help, we intend to further develop and integrate our offerings to deliver a true multi-channel solution that provides significant ROI to our clients.”

“We look forward to working with Chris and his team to continue to expand metanexgen’s capabilities,” said Tony Broglio, a Partner at Insignia. “Reduced access to healthcare practitioners is driving pharmaceutical, biotechnology and medical device companies to spend more on multi-channel marketing services. We believe metanexgen’s full-service offering and technology solutions position the Company at the forefront of the multi-channel marketing sector. We look forward to supporting management to further build upon the Company’s market position with the goal of producing a successful and rewarding outcome for metanexgen’s clients, employees and shareholders.”

Lazard Middle Market LLC served as exclusive financial advisor and Dickstein Shapiro LLP served as legal counsel to the Company. Kirkland & Ellis LLP provided legal counsel to Insignia.

About Insignia Capital Group
Insignia Capital Group is a private equity firm based in the San Francisco Bay Area focused on investing in lower middle-market businesses where it can partner with leading management teams to achieve their true business potential. The firm’s principals have significant experience building businesses across a range of industries including healthcare, business services and consumer. For more information please visit www.insigniacap.com.

About metanexgen
Based in Bensalem, PA, metanexgen is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners. For more information please visit www.metanexgen.com.